InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: None

Saturday, 10/31/2020 4:17:02 PM

Saturday, October 31, 2020 4:17:02 PM

Post# of 35961
Two success stories for COLIN HISLOP:

While at Peninsula he developed Doripenem for systemic infections. Peninsula was bought by J&J and Doripenem has world wide sales in 100 millions.

While at CV Therapeutics developed Ranexa for angina. CV was bought by Gilead and Ranex had yearly sales of 748 million (2016)

Now this heavy hitter is in control of Inspyr.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News